Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications
- PMID: 33639232
- DOI: 10.1016/j.phrs.2021.105520
Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications
Abstract
Diabetes is a metabolic disorder and its incidence is still increasing. Diabetic vascular complications cause major diabetic mobility and include accelerated atherosclerosis, nephropathy, retinopathy, and neuropathy. Hyperglycemia contributes to the pathogenesis of diabetic vascular complications via numerous mechanisms including the induction of oxidative stress, inflammation, metabolic alterations, and abnormal proliferation of EC and angiogenesis. In the past decade, epigenetic modifications have attracted more attention as they participate in the progression of diabetic vascular complications despite controlled glucose levels and regulate gene expression without altering the genomic sequence. DNA methylation and histone methylation, and acetylation are vital epigenetic modifications and their underlying mechanisms in diabetic vascular complication are still urgently needed to be investigated. Non-coding RNAs (nc RNAs) such as micro RNAs (miRNAs), long non-coding RNA (lncRNAs), and circular RNAs (circ RNAs) were found to exert transcriptional regulation in diabetic vascular complication. Although nc RNAs are not considered as epigenetic components, they are involved in epigenetic modifications. In this review, we summarized the investigations of non-coding RNAs involved in DNA methylation and histone methylation and acetylation. Their cross-talks might offer novel insights into the pathology of diabetic vascular complications.
Keywords: DNA methylation; Diabetic vascular complications; Histone acetylation; Histone methylation; Non-coding RNAs.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Epigenetic regulation in diabetic vascular complications.J Mol Endocrinol. 2019 Nov;63(4):R103-R115. doi: 10.1530/JME-19-0170. J Mol Endocrinol. 2019. PMID: 31600719 Review.
-
Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture.Diabetes. 2021 Feb;70(2):328-337. doi: 10.2337/dbi20-0030. Diabetes. 2021. PMID: 33472942 Free PMC article. Review.
-
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.Nat Rev Cardiol. 2015 Aug;12(8):488-97. doi: 10.1038/nrcardio.2015.71. Epub 2015 May 12. Nat Rev Cardiol. 2015. PMID: 25962978 Review.
-
Epigenetic mechanisms in diabetic complications and metabolic memory.Diabetologia. 2015 Mar;58(3):443-55. doi: 10.1007/s00125-014-3462-y. Epub 2014 Dec 7. Diabetologia. 2015. PMID: 25481708 Free PMC article. Review.
-
Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.Biomed Pharmacother. 2019 Sep;117:109192. doi: 10.1016/j.biopha.2019.109192. Epub 2019 Jul 11. Biomed Pharmacother. 2019. PMID: 31387188 Review.
Cited by
-
Posttranslational modifications of proteins in diseased retina.Front Cell Neurosci. 2023 Mar 30;17:1150220. doi: 10.3389/fncel.2023.1150220. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37066080 Free PMC article. Review.
-
Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA.Front Oncol. 2022 May 30;12:835299. doi: 10.3389/fonc.2022.835299. eCollection 2022. Front Oncol. 2022. PMID: 35707350 Free PMC article.
-
Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy via Novel Biomarkers and Competing Endogenous RNA Network.Front Endocrinol (Lausanne). 2022 Jul 14;13:934022. doi: 10.3389/fendo.2022.934022. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909518 Free PMC article.
-
Exploring the epigenetic mechanisms of recurrent pregnancy loss: from genetic predisposition to environmental influences.J Assist Reprod Genet. 2025 Aug 22. doi: 10.1007/s10815-025-03603-5. Online ahead of print. J Assist Reprod Genet. 2025. PMID: 40844725 Review.
-
Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).Int J Mol Med. 2024 Nov;54(5):104. doi: 10.3892/ijmm.2024.5428. Epub 2024 Sep 20. Int J Mol Med. 2024. PMID: 39301658 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous